RespirAq Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $3.3M

  • Investors
  • 8

RespirAq General Information

Description

Developer of medical humidification technology designed to deliver the performance of a heated humidifier at the size, reliability, and simplicity of a heat and moisture exchanger. The company's device is a heated humidifier with an integrated filter that humidifies without additional water and switches between a super-hydrophilic state and a super-hydrophobic state to capture moisture during expiration and inspiration, enabling mechanically ventilated patients with a compact ventilated humidification system.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Level 14, Aut Wo Building
  • 56 Wakefield Street, Auckland central business district
  • Auckland, 1010
  • New Zealand
Primary Industry
Therapeutic Devices
Vertical(s)
Corporate Office
  • Level 14, Aut Wo Building
  • 56 Wakefield Street, Auckland central business district
  • Auckland, 1010
  • New Zealand

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RespirAq Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 01-Jan-2024 $3.3M Completed Generating Revenue
2. Seed Round 26-Jan-2022 Completed Product In Beta Test
1. Grant 01-Jan-2019 $450K Completed Product Development
To view RespirAq’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

RespirAq Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RespirAq Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Clare Ventures Venture Capital Minority
Even Capital (New Zealand) Venture Capital Minority
Movac Venture Capital Minority
New Zealand Trade and Enterprise Government Minority
Cure Kids Ventures Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

RespirAq FAQs

  • When was RespirAq founded?

    RespirAq was founded in 2019.

  • Where is RespirAq headquartered?

    RespirAq is headquartered in Auckland, New Zealand.

  • What is the size of RespirAq?

    RespirAq has 9 total employees.

  • What industry is RespirAq in?

    RespirAq’s primary industry is Therapeutic Devices.

  • Is RespirAq a private or public company?

    RespirAq is a Private company.

  • What is RespirAq’s current revenue?

    The current revenue for RespirAq is .

  • How much funding has RespirAq raised over time?

    RespirAq has raised $4.8M.

  • Who are RespirAq’s investors?

    Clare Ventures, Even Capital (New Zealand), Movac, New Zealand Trade and Enterprise, and Cure Kids Ventures are 5 of 8 investors who have invested in RespirAq.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process